Note: Terms and concepts defined in this report are in addition to those defined in previous ICRU reports (e.g., ICRU Report No. 23 (1973) , Measurement of Absorbed Dose in a Phantom Irradiated by a Single Beam of X or Gamma Rays, and ICRU Report No. 24 (1976) , Determination of Absorbed Dose in a Patient Irradiated by Beams of X or Gamma Rays in Radiotherapy Procedures).
Volumes

Aim of Therapy
A. Curative Treatment of Malignant Disease. In the curative treatment of malignant disease anatomic tumor limits may or may not be demonstrated. When demonstrated, the location and extent of the tumor volume may be determined by means of clinical examination, roentgenologic, radioisotopic, ultrasonic, and microscopic techniques. When the tumor has been previously removed (e.g., by mastectomy or hysterectomy) the remaining tissues may contain occult disease, the limits of which can not be demonstrated.
When planning treatment the volume to be treated to a curative absorbed dose level has to include not only the demonstrated tumor but also its presumed occult spread.
B. Palliative Treatment of Malignant Disease. The palliative treatment of malignant disease may include all or only part of the demonstrated tumor(s) (e.g., irradiation of the spine for a painful deposit in a case of widespread metastases).
C. Non-malignant Diseases. The radiotherapy of non-malignant conditions may or may not include all of the affected tissues (e.g., irradiation of a painful joint in ankylosing spondylitis).
Target Volume
The target volume contains those tissues that are to be irradiated to a specified absorbed dose according to a specified time-dose pattern. For curative treatment the target volume consists of the demonstrated tumor(s), if present, and any other tissue with presumed tumor. 3
The delineation of the target volume will require such considerations as the local invasive capacity of the tumor and its potential to spread to regional lymph nodes. Consideration needs to be given to the presence of any specially radiosensitive normal tissue (organs at risk) as well as to other factors such as the general condition of the patient.
For any given situation there may be more than one target volume.
Physical treatment planning is dependent on the delineation of the target volume(s) and the prescription of the target absorbed dose. These two factors constitute the medical decision which must precede the determination of the dose distribution in the patient. (In the past this sequence has often been reversed and the target volume defined in terms of the dose distribution, for example, the volume enclosed by a particular isodose surface. This procedure is not recommended).
The target volume(s) must always be described, independently of the dose distribution, in terms of the patient's anatomy and topography, and the physical dimensions given. When a dose distribution in one or more anatomical sections is presented, the target volume (or area in a particular section) should be clearly indicated on the diagram. If the whole body section constitutes the target volume, this fact should be indicated on the isodose chart and stated in any accompanying description.
The size and shape of a target volume may change during a course of treatment (e.g., shrinkage of a mediastinal lymphoma), necessitating replanning.
Note: For external beam therapy the following parameters should be taken into account when describing the target volume: a. expected movements (e.g., caused by breathing) of those tissues which contain the target volume relative to anatomic reference points (e.g., skin markings, suprasternal notch), b. expected variation in shape and size of the target volume during a course of treatment (e.g., urinary bladder, stomach), c. inaccuracies or variation in treatment set-up during the course of treatment. An example of target volumes in a patient with a carcinoma of the breast is given in Figure 2 .1. of treatment, or combined with surgery. Example of a target volume which includes not only the breast (in unoperated patients) and the chest wall but also the internal mammary, the supraclavicular, and the· axillary lymph nodes. The target volume appears as a target area (8ihaded area) in the transverse section (b). In practice, as shown in (a) several target volumes have to be identified, which are irradiated with different beams, which partly overlap (From Abbatucci et al., 1972.) 
Definitions of Terms and Co11cepts
Treatment Volume
Because of limitations in treatment techniques it is impossible to administer. the prescribed absorbed dose exclusively to the target volume. In general the volume receiving at least the same absorbed dose as any part of the target volume can not be made to coincide with the target volume but will be larger and often of a simpler shape.
The treatment volume is the volume enclosed by an isodose surface, the value of which is the minimum target absorbed dose (see Section 2.2.3). In some cases the treatment volume may be considerably larger than the target volume, as shown in Figure 3 .2.
Irradiated Volume
The irradiated volume is that volume, larger than the treatment volume, which receives an absorbed dose which is considered significant in relation to tissue tolerance. The significant absorbed dose level can be expressed as absorbed dose in percentage (e.g. 50%) of the specified target absorbed dose (see below) (e.g., Figure 3 .5).
The irradiated volume, as well as the treatment volume, will depend on the treatment technique used.
Organs at Risk
Organs at risk are specially radiosensitive organs in or near the target volume whose presence influence treatment planning and/ or prescribed dose.
Absorbed Dose Pattern
Representation of a Spatial Dose Distribution by a Set of Planar Dose Distributions
A uniform dose distribution can rarely be achieved in a target volume, and it is necessary to evaluate the spatial absorbed dose distribution.
Such an evaluation could be made, in principle, by considering the dose distribution in a set of parallel planar sections sufficiently close to each other (the distance between two sections being equal to the distance between the "lattice points", see Section 2.2.4).
However, for practical reasons only a limited number of sections can be evaluated. These sections may be selected in the following way (Figure 2 .2). The part of the patient containing the target volume and relevant anatomic structures is considered as a stack of several parallel slices, the thickness of the slices being chosen so that in each slice the following conditions are fulfilled: a. no important variations occur in the external contour, b. no important variations occur in the topography of the relevant internal structures: size, shape and location of the target volume, organs at risk, heterogeneities, etc., c. no important variations are expected in the dose distribution that are relevant to the treatment plan. For each slice a section is chosen on which the extreme borders of the target volume, the organs at risk, the tissue heterogeneities and the reference points in that slice are projected perpendicularly. The section then displays all the relevant structures and the part of the target volume which is located within this slice now appears as a target area.
In many simple situations consideration is given only to one section, as illustrated in Figure 2 .3 for a patient with a carcinoma of the urinary bladder.
The following definitions (Sections 2.2.2-2.2. 7) apply to dose calculations in a section. They are clinically relevant only if they can be assumed to represent the corresponding spatial situation.
2.2.2 Maximum Target Absorbed Dose (Dr.max) The maximum target absorbed dose is the highest absorbed dose in the target area that can be regarded as "clinically meaningful". The latter term implies that at least a minimum area is irradiated to the dose level designated as "maximum". The minimum area recommended for this purpose is 2 cm 2 , unless the whole target area is less than 4 cm 2 , in which case a minimum area of 1 cm 2 should be taken to define the maximum target absorbed dose.
The value 2 cm 2 is based on two considerations. First, 2 cm 2 represents approximately the smallest area for which the absorbed dose can be calculated with confidence, either manually or with a computer; second, the maximum target absorbed dose is often related to the limiting effects of treatment such as tissue tolerance and the smallest volume of tissue to which these effects apply is considered to be that volume whose section is at least 2 cm 2 • Within an isodose curve enclosing an area of 2 cm 2 the dose at a point may be even higher, but it is recommended that such hot points be ignored in designating the value of the maximum target absorbed dose.
Minimum Target Absorbed Dose (Dr.min)
The minimum target absorbed dose is the lowest absorbed dose in the target area. No area limit is recommended when reporting minimum target absorbed dose.
Mean Target Absorbed Dose (Dr.mean)
For the determination of the mean, as well as of the median and modal target absorbed dose, it is necessary to calculate the dose at each of a large number of discrete points (lattice points), uniformly distributed in the target area.
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The mean target absorbed dose is then calculated as the mean of the absorbed dose values in these lattice points and can be expressed by the equation:
where N is the number oflattice points, i is the column index in this lattice, j is the row index, and Di,i is the absorbed dose at the lattice point i,j located inside the target area AT.
Median Target Absorbed Dose (Dr.median)
The median target absorbed dose is the central value among the set of values of the absorbed dose at all lattice points in the target area, when arranged according to magnitude. (Dr, moda1) The modal target absorbed dose is the absorbed dose that occurs most frequently at lattice points in the target area. Its value may be influenced by the choice of method for its calculation (e.g., spacing of lattice points). Exceptionally, in a particular patient, more than one modal target absorbed dose may be found.
Modal Target Absorbed Dose
An example of a computerized calculation of the different above-mentioned target absorbed doses in one section of a patient is given in Figure 2 .4.
7 Hot Spots
In many situations tissues outside the target area will receive a relatively high absorbed dose. A hot spot is an area which receives an absorbed dose higher than 100% of the specified target absorbed dose (see Section 3.3). However, as in the case of the maximum target absorbed dose (see Section 2.2.2), a hot spot is considered clinically meaningful only if the corresponding isodose curve encloses an area of at least 2 cm 2 in a section. a
Definitions of Terms and Concepts
-·-· -·-· -·-·-4-<M:· . . . ·;/J-· -·---·-·--II -·-· ---·-· -·-g · -·-·-·-·-·-·-·-III 2.2(a) . Example of a multi-section dose plan for the curative treatment of a carcinoma of the nasopharynx (demonstrated tumor= target A, indicated by black) and its presumed spread to the regional lymph nodes in the neck and supraclavicular fossae (subclinical disease = target B, indicated by the dotted line (Figure 2.2(a) ) or honeycombed area (Figure 2.2(b), page 7) . The prescribed absorbed dose for target A is higher than that for target B. The organs at risk are the spinal cord, brafu stem, and to some extent the eyes. When calculating the absorbed dose distribution, correction for tissue heterogeneity (lung tissue and bone) may be applied. The preliminary suggestion for treatment technique is a multifield arrangement with lateral fields towards target A and one anterior and two oblique posterior fields towards target B, in order to keep the dose to organs at risk as low as possible. After having defined optimal patient positioning with respect to suggested treatment technique, representative sections will be produced. In this case, 5 sections (I-V) were needed for the calculation of the absorbed dose pattern because of variation in shape and size of the two target volumes, outline of the patient and treatment technique. Each section represents one slice of the patient. The extreme borders of the target volume, organs at risk, tissue heterogeneities and reference points in that slice have been projected perpendicularly on to the section, thus defining the target area and other relevant structures ut;.the section. 
Sagittal (or lateral) projection (lateral ~adiograph)
Frontal projection (A.P. radiograph) lransverse (or cross) section Fig. 2.3 . Example of a target in a patient with localized cancer of the urinary bladder and presumed occult spread. The transverse section is considered to be representative of the whole target volume and the relevant normal tissues. For the graphical construction of the transverse section two radiographs are used that represent two perpendicular projections of the anatomy of interest. The border of the target is indicated by the dotted line. The target appears in the two radiographs and is indicated as an area in the section. It includes the demonstrated tumor (indicated in black). the whole bladder and the regional lymph nodes (the iliac and the obturator groups) as well as connecting lymphatics. Transverse section of the patient. The calculation of the absorbed dose includes correction for tissue heterogeneity, the "effective density" of the lung tissue being considered to be 500 kg m -3 and that of bone to be 1300 kg m-3 • The border of the target area is indicated by the thick line. The display gives the distribution of the absorbed dose and also the position of the maximum (4) and the minimum<•> target absorbed dose. In this special case, the weighting of the beams (peak absorbed dose 50%, 45%, and 45%, respectively), was chosen to give an absorbed dose of 100% at the point of intersection of the central axes of the three beams. for 21 equally large intervals of absorbed dose percentage values, ranging from 102% to 93%. The maximum target absorbed dose considered to be meaningful and to be used for reporting (see Section 2.2.2) is 100%. The modal target absorbed dose is 99%, and the median 98%. The computation also gives the mean target absorbed dose ( -t----,.---,.-----r-..u.L ....... . 
